| 01/22/01 | Eli Lilly : a finalisé l'acquisition d'Akouos | |
| 30/22/30 | Eli Lilly : vers l'acquisition de 81.1% des actions d'Akouos | |
| 19/22/19 | Wall Street sluit hoger | |
| 19/22/19 | Wall Street houdt winst vast | |
| 18/22/18 | MÄRKTE USA/Börsen setzen Erholung fort |
| 1 day | +1.06% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 43 | 01/01/2016 | |
Jean Phillips
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aaron Tward
CTO | Chief Tech/Sci/R&D Officer | - | 10/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jean Bennett
BRD | Director/Board Member | 71 | 01/01/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/12/22 | Issuer sale | Chief Financial Officer | 1,50,000 | 0.4060% | ||
| 01/12/22 | Issuer sale | Director | 16,000 | 0.0433% | ||
| 01/12/22 | Issuer sale | Director | 16,000 | 0.0433% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.06% | +0.91% | - | - | 49Cr | |
| +0.93% | +6.97% | +59.60% | +68.35% | 5.73TCr | |
| -1.92% | +6.03% | +40.64% | +83.42% | 5.5TCr | |
| -0.46% | -1.29% | +2.86% | +428.78% | 2.32TCr | |
| -2.97% | -2.35% | -22.53% | -16.40% | 2.26TCr | |
| -0.36% | +5.73% | +24.13% | -6.24% | 2.05TCr | |
| -1.34% | +0.51% | +26.03% | -29.41% | 1.76TCr | |
| -1.44% | +5.67% | +38.77% | +504.71% | 1.57TCr | |
| -1.30% | -5.02% | +170.77% | +291.37% | 1.45TCr | |
| -0.50% | -0.98% | +21.43% | +180.07% | 1.39TCr | |
| Average | -0.83% | +1.28% | +40.19% | +167.18% | 2.67TCr | |
| Weighted average by Cap. | -0.87% | +2.10% | +39.70% | +133.49% |
Employees
103
